Fundz

Clinilabs Appoints Bob Dagher as Chief Medical Officer

PRIVATEAug 05, 2026

Position

Chief Medical Officer

Company

Clinilabs

Bob Dagher
New JerseyBiotechnologyHealth CareEducationMedical

Description

Clinilabs has announced the appointment of Bob Dagher, M.D., as Chief Medical Officer. Dr. Dagher will provide strategic and medical leadership across the organization.

Quick answer

Clinilabs Appoints Bob Dagher as Chief Medical Officer (August 5, 2026). Clinilabs is based in New Jersey, United States.

Who is the new Chief Medical Officer at Clinilabs?
Clinilabs named Bob Dagher Chief Medical Officer, announced August 5, 2026.
What did Clinilabs announce on August 5, 2026?
Clinilabs has announced the appointment of Bob Dagher, M.D., as Chief Medical Officer. Dr. Dagher will provide strategic and medical leadership across the organization.
What does Clinilabs do?
Clinilabs LLC is a global full-service CRO specializing in CNS drug and device development.
Where is Clinilabs based?
Clinilabs is based in New Jersey, United States.
Which similar companies made leadership changes around the same time?
American Society for Clinical Pathology (August 10, 2026), The Society of Thoracic Surgeons (July 28, 2026), UT Health San Antonio (August 24, 2026) and Soris Pain & Vascular Institute (August 26, 2026) also announced leadership changes within 45 days of Clinilabs.

Source: Fundz verified event record.

Other recent leadership changes in Education and Medical

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Clinilabs, and when

A new leader at Clinilabs brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Clinilabs raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Clinilabs, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Clinilabs. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Clinilabs

Location

New Jersey, United States

About

Clinilabs LLC is a global full-service CRO specializing in CNS drug and device development. The company focuses on advancing scientific education and strengthening the future clinical research workforce. They provide hands-on clinical research experience through various programs. Clinilabs aims to enhance operational protocols in clinical research.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Clinilabs changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Anne
Senior decision-maker at this company
••••••••@••••••••

See Anne's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Clinilabs's next move

Learn about Strategic plan

Clinilabs changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.